Foresite Capital Management II’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
2017
Q3
$1.11M Sell
2017
Q2
$1.75M Sell
2017
Q1
$2.14M Buy
2016
Q4
$944K Hold
2016
Q3
$1.8M Sell
2016
Q2
$2.33M Sell
2016
Q1
$3.64M Buy
2015
Q4
$10.7M Buy
2015
Q3
$8.91M Buy
2015
Q2
$20.8M Hold
2015
Q1
$32.9M Buy
2014
Q4
$24.3M Buy